Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells - PubMed (original) (raw)
Comparative Study
. 2005 Dec 15;65(24):11375-83.
doi: 10.1158/0008-5472.CAN-05-1602.
Affiliations
- PMID: 16357145
- DOI: 10.1158/0008-5472.CAN-05-1602
Comparative Study
Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells
Sean F Eddy et al. Cancer Res. 2005.
Abstract
Aberrant activation of nuclear factor-kappaB (NF-kappaB) transcription factors has been implicated in the pathogenesis of breast cancer. We previously showed elevated activity of IkappaB kinase alpha (IKKalpha), IKKbeta, and protein kinase CK2 in primary human breast cancer specimens and cultured cells. A novel inducible IKK protein termed IKK-i/IKKepsilon has been characterized as a potential NF-kappaB activator. Here, we provide evidence that implicates IKK-i/IKKepsilon in the pathogenesis of breast cancer. We show IKK-i/IKKepsilon expression in primary human breast cancer specimens and carcinogen-induced mouse mammary tumors. Multiple breast cancer cell lines showed higher levels of IKK-i/IKKepsilon and kinase activity compared with untransformed MCF-10F breast epithelial cells. Interestingly, IKK-i/IKKepsilon expression correlated with CK2alpha expression in mammary glands and breast tumors derived from MMTV-CK2alpha transgenic mice. Ectopic CK2 expression in untransformed cells led to increased IKK-i/IKKepsilon mRNA and protein levels. Inhibition of CK2alpha via the pharmacologic inhibitor apigenin or upon transfection of a CK2 kinase-inactive subunit reduced IKK-i/IKKepsilon levels. Expression of a kinase-inactive IKK-i/IKKepsilon mutant in breast cancer cells reduced NF-kappaB activity as judged by transfection assays of reporters driven either by NF-kappaB elements or the promoters of two NF-kappaB target genes, cyclin D1 and relB. Importantly, the kinase-inactive IKK-i/IKKepsilon mutant reduced the endogenous levels of these genes as well as the ability of breast cancer cells to grow in soft agar or form invasive colonies in Matrigel. Thus, CK2 induces functional IKK-i/IKKepsilon, which is an important mediator of the activation of NF-kappaB that plays a critical role in the pathogenesis of breast cancer.
Similar articles
- Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE. Romieu-Mourez R, et al. Cancer Res. 2001 May 1;61(9):3810-8. Cancer Res. 2001. PMID: 11325857 - Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE. Romieu-Mourez R, et al. Cancer Res. 2002 Nov 15;62(22):6770-8. Cancer Res. 2002. PMID: 12438279 - RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE. Demicco EG, et al. Mol Cell Biol. 2005 Nov;25(22):10136-47. doi: 10.1128/MCB.25.22.10136-10147.2005. Mol Cell Biol. 2005. PMID: 16260626 Free PMC article. - Regulation and function of IKK and IKK-related kinases.
Häcker H, Karin M. Häcker H, et al. Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review. - How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.
Karin M. Karin M. Oncogene. 1999 Nov 22;18(49):6867-74. doi: 10.1038/sj.onc.1203219. Oncogene. 1999. PMID: 10602462 Review.
Cited by
- Human cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is dimeric in its disulfide-reduced state, with natively disordered N-terminal region.
Ertekin A, Aramini JM, Rossi P, Leonard PG, Janjua H, Xiao R, Maglaqui M, Lee HW, Prestegard JH, Montelione GT. Ertekin A, et al. J Biol Chem. 2012 May 11;287(20):16541-9. doi: 10.1074/jbc.M112.343863. Epub 2012 Mar 14. J Biol Chem. 2012. PMID: 22427660 Free PMC article. - Potentiation of tumor necrosis factor-alpha-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4.
Qiu J, Xiao J, Han C, Li N, Shen X, Jiang H, Cao X. Qiu J, et al. J Biol Chem. 2010 Apr 16;285(16):12241-7. doi: 10.1074/jbc.M110.111898. Epub 2010 Feb 22. J Biol Chem. 2010. PMID: 20177075 Free PMC article. - CK2 and the Hallmarks of Cancer.
Firnau MB, Brieger A. Firnau MB, et al. Biomedicines. 2022 Aug 16;10(8):1987. doi: 10.3390/biomedicines10081987. Biomedicines. 2022. PMID: 36009534 Free PMC article. Review. - Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth.
Barbie TU, Alexe G, Aref AR, Li S, Zhu Z, Zhang X, Imamura Y, Thai TC, Huang Y, Bowden M, Herndon J, Cohoon TJ, Fleming T, Tamayo P, Mesirov JP, Ogino S, Wong KK, Ellis MJ, Hahn WC, Barbie DA, Gillanders WE. Barbie TU, et al. J Clin Invest. 2014 Dec;124(12):5411-23. doi: 10.1172/JCI75661. Epub 2014 Nov 3. J Clin Invest. 2014. PMID: 25365225 Free PMC article. Clinical Trial. - Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma.
Nasry WHS, Martin CK. Nasry WHS, et al. Front Oncol. 2021 May 21;11:539361. doi: 10.3389/fonc.2021.539361. eCollection 2021. Front Oncol. 2021. PMID: 34094895 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials